Novel antiplatelet drug Revacept (dimeric glycoprotein VI-Fc) specifically and efficiently inhibited collagen-induced platelet aggregation without affecting general hemostasis in humans - Ungerer, M; Rosport, K; Bultmann, A (Circulation, 2011)
et al.